Egypt’s Rameda gets requests to export COVID-19 drug

Egypt’s Rameda Pharmaceutical has received requests to export Anviziram tablets, which are used to treat patients with the new coronavirus. (Shutterstock)
Short Url
Updated 25 June 2020

Egypt’s Rameda gets requests to export COVID-19 drug

  • Egypt’s Rameda Pharmaceutical has received requests to Saudi Arabia, Kuwait, Iraq and Yemen
  • The company is providing the drug to the Egyptian health ministry to be used in hospitals

ALEXANDRIA: Egypt’s Rameda Pharmaceutical has received requests to export Anviziram tablets, which are used to treat patients with the new coronavirus, to Saudi Arabia, Kuwait, Iraq and Yemen, but needs a government approval first, its CEO told Reuters.
The company said earlier this month it had started manufacturing Anviziram, the generic equivalent of the Japanese antiviral Avigan, and had also received an approval from the Egyptian Drug Authority to manufacture Remedsivir, a Gilead Sciences Inc. antiviral used for treating COVID-19.
Rameda, which listed 49 percent of its shares on the Egyptian exchange last year, has produced quantities enough Anviziram tablets to cover “appropriate numbers of patients in the Egyptian market,” said its CEO Amr Mursi.
The company is providing the drug to the Egyptian health ministry to be used in hospitals. Mursi said it would be available to the public before the end of July, adding its commercial price was still being negotiated.
He expects more requests from Gulf countries to import Anviziram, but the company’s response depends on the approval of the Egyptian authorities.
“We will discuss this with them next week to see whether we will be able to export or not,” Mursi said.


Iran reports highest daily coronavirus infections since Feb

Updated 21 October 2020

Iran reports highest daily coronavirus infections since Feb

  • 312 people died from the disease in the past 24 hours, bringing total fatalities to 31,346
  • It is the second consecutive day that the country has seen record figures

DUBAI: Iran’s health ministry on Wednesday reported 5,616 new coronavirus cases for the previous 24 hours, the highest daily number since February, bringing the national tally to 545,286 in the Middle East’s hardest-hit country.
Ministry spokeswoman Sima Sadat Lari told state TV that 312 people had died from the disease in the past 24 hours, bringing total fatalities to 31,346.
To stem a third wave of the outbreak, authorities have urged people to avoid unnecessary trips and stay home, warning that hospitals in Tehran and some other major cities are overflowing with coronavirus patients.
On Tuesday, Health Minister Saeed Namaki appealed for more public and government support to enforce restrictions to curb the spread of the virus. Earlier this month, mask-wearing became mandatory in public in Tehran, where the government said violators would be fined. The government on Saturday extended restrictions and closures in the capital into a third week.
Authorities plan to impose similar restrictions in other cities, where the infection rates are high.